KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nutrien (NTR) Other Operating Expenses (2016 - 2026)

Nutrien has reported Other Operating Expenses over the past 11 years, most recently at $114.0 million for Q1 2026.

  • For Q1 2026, Other Operating Expenses rose 67.65% year-over-year to $114.0 million; the TTM value through Mar 2026 reached $494.0 million, up 15.42%, while the annual FY2025 figure was -$448.0 million, 8.47% down from the prior year.
  • Other Operating Expenses for Q1 2026 was $114.0 million at Nutrien, down from $177.0 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $319.0 million in Q4 2023 and troughed at $9.0 million in Q2 2024.
  • A 5-year average of $104.8 million and a median of $93.5 million in 2022 define the central range for Other Operating Expenses.
  • Biggest five-year swings in Other Operating Expenses: crashed 91.96% in 2024 and later surged 1300.0% in 2025.
  • Year by year, Other Operating Expenses stood at $110.0 million in 2022, then surged by 190.0% to $319.0 million in 2023, then tumbled by 59.56% to $129.0 million in 2024, then soared by 37.21% to $177.0 million in 2025, then plummeted by 35.59% to $114.0 million in 2026.
  • Business Quant data shows Other Operating Expenses for NTR at $114.0 million in Q1 2026, $177.0 million in Q4 2025, and $77.0 million in Q3 2025.